Efficacy of fiducial marker-based image-guided radiation therapy in prostate tomotherapy and potential dose coverage improvement using a patient positioning optimization method

Practical Radiation Oncology

Volumn 2, Issue 2, 2012, Pages 138-144

  Yue, Ning J ^a   Patel, Akshar N ^a   Haffty, Bruce G ^a   Kim, Sung ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTRIBUTION VOLUME; DOSE CALCULATION; DOSE RESPONSE; DOSIMETRY; FIDUCIAL MARKER; HUMAN; IMAGE GUIDED RADIOTHERAPY; PATIENT POSITIONING; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROSTATE; RADIATION DOSE DISTRIBUTION; SEMINAL VESICLE; THERAPY EFFECT; TOMOTHERAPY;

EID: 84858865234     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2011.07.006     Document Type: Article

References (20)

1. Zelefsky M.J., Chan H., Hunt M., Yamada Y., Shippy A.M., Amols H. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 2006, 176(4 Pt 1):1415-1419.
2. Bos L.J., van der Geer J., van Herk M., Mijnheer B.J., Lebesque J.V., Damen E.M.F. The sensitivity of dose distributions for organ motion and set-up uncertainties in prostate IMRT. Radiother Oncol 2005, 76:18-26.
3. Rudat V., Schraube P., Oetzel D., Zierhut D., Flentje M., Wannenmacher M. Combined error of patient positioning variability and prostate motion uncertainty in 3D conformal radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 1996, 35:1027-1034.
4. Roach M., Faillace-Akazawa P., Malfatti C. Prostate volumes and organ movement defined by serial computerized tomographic scans during three-dimensional conformal radiotherapy. Radiat Oncol Invest 1997, 5:187-194.
5. Crook J.M., Raymond Y., Salhani D., Yang H., Esche B. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 1995, 37(1):35-42.
6. Alasti H., Petric M.P., Catton C.N., Warde P.R. Portal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001, 49:869-884.
7. van der Wielen G.J., Mutanga T.F., Incrocci L., et al. Deformation of prostate and seminal vesicles relative to intraprostatic fiducial markers. Int J Radiat Oncol Biol Phys 2008, 72:1604-1611.
8. Frank S.J., Dong L., Kudchadker R.J., et al. Quantification of prostate and seminal vesicles interfraction variation during IMRT. Int J Radiat Oncol Biol Phys 2008, 71:813-820.
9. Mao W., Hsu A., Riaz N., et al. Image-guided radiotherapy in near real time with intensity-modulated radiotherapy megavoltage treatment beam imaging. Int J Radiat Oncol Biol Phys 2009, 75:603-610.
10. Barney B.M., Lee R.J., Handrahan D., Welsh K.T., Cook J.T., Sause W.T. Image-guided radiotherapy (IGRT) for prostate cancer comparing kv imaging of fiducial markers with cone beam computed tomography (CBCT). Int J Radiat Oncol Biol Phys 2011, 80:301-305.
11. Khosa R., Nangia S., Chufal K.S., Ghosh D., Kaul R., Sharma L. Daily online localization using implanted fiducial markers and its impact on planning target volume for carcinoma prostate. J Cancer Res Ther 2010, 6:172-178.
12. Owen R., Foroudi F., Kron T., et al. A comparison of in-room computerized tomography options for detection of fiducial markers in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2010, 77:1248-1256.
13. Skarsgard D., Cadman P., El-Gayed A., et al. Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers. Radiat Oncol 2010, 5:52.
14. Tanyi J.A., He T., Summers P.A., et al. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion. Int J Radiat Oncol Biol Phys 2010, 78:1579-1585.
15. Langen K.M., Zhang Y., Andrews R.D., et al. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. Int J Radiat Oncol Biol Phys 2005, 62:1517-1524.
16. Gauthier I., Carrier J.F., Béliveau-Nadeau D., Fortin B., Taussky D. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment. Int J Radiat Oncol Biol Phys 2009, 74:1128-1133.
17. Graf R., Boehmer D., Budach V., Wust P. Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials. Strahlenther Onkol 2010, 186:544-550.
18. Delouya G., Carrier J.F., Béliveau-Nadeau D., Donath D., Taussky D. Migration of intraprostatic fiducial markers and its influence on the matching quality in external beam radiation therapy for prostate cancer. Radiother Oncol 2010, 96:43-47.
19. van Haaren P.M., Bel A., Hofman P., van Vulpen M., Kotte A.N., van der Heide U.A. Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients. Radiother Oncol 2009, 90:291-298.
20. Russell S., Norvig P. Artificial intelligence: a modern approach 2003, 111-114. Prentice Hall, Upper Saddle River, NJ. 2nd ed.